$1B Alliance Between Menarini, Oxford BioTherapeutics for Enhanced AML Treatment
Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announce that they have initiated the first-in-human clinical study... Read More